C
grade
Toxicological evaluation of a recombinant inulosucrase (Convero®) produced by precision fermentation: <i>In vitro</i> genotoxicity studies and 28-day oral toxicity study in rats.
Efsubaglutide · Toxicology reports · 2026 · Observational · Preclinical
Convero® showed no evidence of toxicity in rats at doses up to 2000 mg TOS/kg bw/day, indicating potential safety for food applications.
No evidence of oral toxicity observed at doses up to 2000 mg TOS/kg bw/day.